Healthtech Startup Inito Raises $29 Mn to Expand At-Home Diagnostics Platform
The company aims to expand its offerings beyond fertility and build a broader at-home hormone and health diagnostics platform powered by AI-engineered antibodies.
Healthtech startup Inito has raised $29 Mn (INR 261.9 Cr) in a Series B funding round co-led by Bertelsmann India Investments (BII) and existing investor Fireside Ventures.
The company aims to expand its offerings beyond fertility and build a broader at-home hormone and health diagnostics platform powered by AI-engineered antibodies.
“The new capital accelerates Inito’s work that allows diagnostic tests to be designed in silico rather than developed through slow, inconsistent, animal-based methods, setting the stage for faster innovation and a wider range of at-home tests that can reach more people worldwide,” the startup said in a statement.
Founded in 2015 by Aayush Rai and Varun AV, Inito provides tools for at-home health checkups and management. Its flagship fertility monitor tracks fertility hormones in 10 minutes and offers advanced personalised analytics about reproductive health.
The Bengaluru-based startup holds more than 20 patents and has a database of over 30 Mn fertility hormone tests. With the expanding database, Inito is strengthening its team across Dubai, Bengaluru and London.
Before this round, Inito had raised about $16 Mn from Fireside Ventures, Y Combinator and several physicians and family offices. Its profit rose to INR 7.7 Cr in FY24 from INR 11 Lakh in FY23, while total revenue more than doubled year-on-year to INR 53 Cr.
The startup has not yet disclosed its FY25 financials.
The funding arrives at a time when at-home diagnostics is gaining traction across age groups. Services such as sample collection, lab tests, consultations, and medicine delivery have become increasingly accessible and affordable.
The expanding demand has encouraged several companies to widen their diagnostics offerings. In June, Amazon entered the healthcare segment with Amazon Diagnostics, enabling customers to book tests, schedule appointments and access digital reports through the app.
Stay tuned for more such updates on Digital Health News